These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1379 related items for PubMed ID: 12365081

  • 1. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B, Guilhot J, Salanave B, Fender P, Allemand H.
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P, Guilhot J, Tilly B, Salanave B, Allemand H.
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [Abstract] [Full Text] [Related]

  • 3. [A comparison of the management of severe high blood pressure between 1999 and 2003 in France].
    Bertin N, Salanave B, Tilly B, Guilhot J, Ricordeau P, Fender P, Dematons MN, Treppoz H, Allemand H.
    Arch Mal Coeur Vaiss; 2004; 97(7-8):793-8. PubMed ID: 15506068
    [Abstract] [Full Text] [Related]

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 5. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD, Canadian Hypertension Education Program.
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Changes in life style and drug therapy for treatment of hypertension in France between 2002 and 2004].
    Girerd X, Herpin D, Postel-Vinay N, Vaïsse B, Poncelet P, Mallion JM, Murino M, Mourad JJ.
    Arch Mal Coeur Vaiss; 2005 Jun; 98(7-8):813-6. PubMed ID: 16220753
    [Abstract] [Full Text] [Related]

  • 9. [Differences between management guidelines and global health strategies for arterial hypertension with metabolic disorders in France in 1999. Ohara study].
    Mallion JM, Kahn JC, Poncelet P, Pannier B, Vaïsse B, Koch C, Phan TM, Pithois-Merli I.
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):834-8. PubMed ID: 11575213
    [Abstract] [Full Text] [Related]

  • 10. Lack of control of high blood pressure and treatment recommendations in Canada.
    Khan N, Chockalingam A, Campbell NR.
    Can J Cardiol; 2002 Jun; 18(6):657-61. PubMed ID: 12107423
    [Abstract] [Full Text] [Related]

  • 11. [Prevalence, treatment and control of hypertension in family practice patients in France during 1994].
    Poggi L, Chamontin B, Lang T, Menard J, Chevalier H, Gallois H, Cremier O.
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1075-80. PubMed ID: 8949382
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Results of the "Health Program Hypertension" of the German Health Insurance (DKV)].
    Lickvers K, Kottmair S, Rose I, Müller M, Middeke M.
    Dtsch Med Wochenschr; 2005 Nov 18; 130(46):2628-30. PubMed ID: 16281157
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine].
    Denolle T, Eon Y, Le Néel H, Seignard H, Battini J.
    Arch Mal Coeur Vaiss; 2005 Nov 18; 98(7-8):761-6. PubMed ID: 16220744
    [Abstract] [Full Text] [Related]

  • 19. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 18; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 20. [Application of French guidelines in newly diagnosed hypertensive patients managed by general practitioners].
    Hanon O, Hoguin JC, Girerd X.
    Arch Mal Coeur Vaiss; 2003 Apr 18; 96(7-8):744-7. PubMed ID: 12945215
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 69.